Emerging paradigm: Toll-like receptor 4 - Sentinel for the detection of tissue damage

Shock

Volumn 26, Issue 5, 2006, Pages 430-437

  Mollen, Kevin P ^a   Anand, Rahul J ^a   Tsung, Allan ^a   Prince, Jose M ^a   Levy, Ryan M ^a   Billiar, Timothy R ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Acute injury; Danger signals; Hemorrhagic shock (HS); HMGB1; Innate immunity; Ischemia reperfusion (I R); Toxic exposure; Trauma

Indexed keywords

CD14 ANTIGEN; CD36 ANTIGEN; DROSOPHILA PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROTEIN MD 2; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

HEMORRHAGIC SHOCK; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; ISCHEMIA; NONHUMAN; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE INJURY; WOUND HEALING;

ANIMALS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; LIPOPOLYSACCHARIDES; REPERFUSION INJURY; SHOCK, HEMORRHAGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; WOUND HEALING; WOUNDS AND INJURIES;

EID: 33750312909     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000228797.41044.08     Document Type: Review

References (66)

1. Medzhitov R, Janeway C Jr: Innate immunity. N Engl J Med 343:338-344, 2000.
2. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145, 2001.
3. Luster AD: The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 14:129-135, 2002.
4. Beutler B: Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-263, 2004.
5. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC: Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 40:501-510, 1996.
6. Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR: Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 202:407-417, 2006.
7. Levy RM, Prince JM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR: Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. Am J Physiol Regul Integr Comp Physiol 291:R970-R976, 2006.
8. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, et al: CD36 is a sensor of diacylglycerides. Nature 433:523-527, 2005.
9. Beutler B, Hoebe K, Du X, Ulevitch RJ: How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74:479-485, 2003.
10. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-983, 1996.
11. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397, 1997.
12. Beutler B: The Toll-like receptors: analysis by forward genetic methods. Immunogenetics 57:385-392, 2005.
13. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088, 1998.
14. Hopkins PA, Sriskandan S: Mammalian Toll-like receptors: to immunity and beyond. Clin Exp Immunol 140:395-407, 2005.
15. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O'Neill LA, Hertzog PJ: Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol 7:148-155, 2006.
16. Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, McIntyre RC: Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 287:R592-R599, 2004.
17. Oyama J, Blais C, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T: Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109:784-789, 2004.
18. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van't Veer C: In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168:1286-1293, 2002.
19. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, et al: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135-1143, 2005.
20. Zhai Y, Shen XD, O'Connell R, Gao F, Lassman C, Busuttil RW, Cheng G, Kupiec-Weglinski JW: Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173:7115-7119, 2004.
21. DeMaria EJ, Pellicane JV, Lee RB: Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor. J Trauma 35:720-724, 1993.
22. Pellicane JV, Gore DC, DeMaria EJ: Decreased lactate in endotoxin-resistant mice undergoing hemorrhage is independent of tumor necrosis factor availability. J Surg Res 56:361-366, 1994.
23. Bettinger DA, Pellicane JV, Tarry WC, Yager DR, Diegelmann RF, Lee R, Cohen IK, DeMaria EJ: The role of inflammatory cytokines in wound healing: accelerated healing in endotoxin-resistant mice. J Trauma 36:810-813, 1994.
24. Ayala A, Perrin MM, Meldrum DR, Ertel W, Chaudry IH: Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2:170-174, 1990.
25. Hierholzer C, Billiar TR: Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 386:302-308, 2001.
26. Meng X, Ao L, Song Y, Raeburn CD, Fullerton DA, Harken AH: Signaling for myocardial depression in hemorrhagic shock: roles of Toll-like receptor 4 and p55 TNF-alpha receptor. Am J Physiol Regul Integr Comp Physiol 288:R600-R606, 2005.
27. Kim JY, Park JS, Strassheim D, Douglas I, Diaz d V, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, et al: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288:L958-L965, 2005.
28. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377, 2004.
29. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, Yang L, Yang H, Tracey KJ, Harbrecht BG, et al: Delayed Treatment with anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival in mice subjected to hemorrhagic shock. Mol Med 2006. In press.
30. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, et al: High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917-C924, 2006.
31. Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, Cheng G, Kupiec-Weglinski JW: Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 5:1793-1800, 2005.
32. Wu HS, Zhang JX, Wang L, Tian Y, Wang H, Rotstein O: Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 3:250-253, 2004.
33. Ke B, Shen XD, Gao F, Busuttil RW, Kupiec-Weglinski JW: Interleukin 13 gene transfer in liver ischemia and reperfusion injury: role of Stat6 and TLR4 pathways in cytoprotection. Hum Gene Ther 15:691-698, 2004.
34. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, Lotze MT, Geller DA, Billiar TR: Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 175:7661-7668, 2005.
35. Jobin N, Garrel DR, Bernier J: Increased burn-induced immunosuppression in lipopolysaccharide-resistant mice. Cell Immunol 200:65-75, 2000.
36. Thomas JA, Tsen MF, White DJ, Horton JW: TLR4 inactivation and rBPI(21) block burn-induced myocardial contractile dysfunction. Am J Physiol Heart Circ Physiol 283:H1645-H1655, 2002.
37. Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW, Lee PJ: Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 175:4834-4838, 2005.
38. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, et al: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11:1173-1179, 2005.
39. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K, Nast CC, Lechago J, Xu R, Naiki Y, et al: Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288:G1055-G1065, 2005.
40. Ohkawara T, Takeda H, Nishihira J, Miyashita K, Nihiwaki M, Ishiguro Y, Takeda K, Akira S, Iwanaga T, Sugiyama T, et al: Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice. Clin Exp Immunol 141:412-421, 2005.
41. Stevceva L, Pavli P, Buffinton G, Wozniak A, Doe WF: Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive mice. J Gastroenterol Hepatol 14:54-60, 1999.
42. Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG: Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34:101-108, 2001.
43. Cho HY, Jedlicka AE, Clarke R, Kleeberger SR: Role of Toll-like receptor-4 in genetic susceptibility to lung injury induced by residual oil fly ash. Physiol Genomics 22:108-117, 2005.
44. Hollingsworth JW, Cook DN, Brass DM, Walker JK, Morgan DL, Foster WM, Schwartz DA: The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 170:126-132, 2004.
45. Kleeberger SR, Reddy S, Zhang LY, Jedlicka AE: Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol 22:620-627, 2000.
46. Kleeberger SR, Reddy SP, Zhang LY, Cho HY, Jedlicka AE: Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 280:L326-L333, 2001.
47. Johnson GB, Brunn GJ, Platt JL: Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol 172:20-24, 2004.
48. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Marshall JC, Frantz S, Kelly RA, Medzhitov R, Rotstein OD: Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol 168:5252-5259, 2002.
49. Ayala A, Chung CS, Lomas JL, Song GY, Doughty LA, Gregory SH, Cioffi WG, LeBlanc BW, Reichner J, Simms HH, et al: Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol 161:2283-2294, 2002.
50. Fan J, Li Y, Vodovotz Y, Billiar TR, Wilson MA: Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages:role in hemorrhage primed lung inflammation. Am J Physiol Lung Cell Mol Physiol 290(4):L738-L746, 2006.
51. Paterson HM, Murphy TJ, Purcell EJ, Shelley O, Kriynovich SJ, Lien E, Mannick JA, Lederer JA: Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 171:1473-1483, 2003.
52. Murphy TJ, Paterson HM, Mannick JA, Lederer JA: Injury, sepsis, and the regulation of Toll-like receptor responses. J Leukoc Biol 75:400-407, 2004.
53. Maung AA, Fujimi S, Miller ML, MacConmara MP, Mannick JA, Lederer JA: Enhanced TLR4 reactivity following injury is mediated by increased p38 activation. J Leukoc Biol 78:565-573, 2005.
54. Cho K, Pham TN, Crivello SD, Jeong J, Green TL, Greenhalgh DG: Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Shock 21:144-150, 2004.
55. Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045, 1994.
56. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL: Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279:17079-17084, 2004.
57. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC: Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99-111, 2002.
58. Johnson GB, Brunn GJ, Kodaira Y, Platt JL: Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168:5233-5239, 2002.
59. Smiley ST, King JA, Hancock WW: Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167:2887-2894, 2001.
60. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
61. Ohashi K, Burkart V, Flohe S, Kolb H: Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558-561, 2000.
62. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D: mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279:12542-12550, 2004.
63. Sivori S, Falco M, Della CM, Carlomagno S, Vitale M, Moretta L, Moretta A: CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A 101:10116-10121, 2004.
64. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202:1131-1139, 2005.
65. Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, Forsbach A, Akira S, Kelly KM, Reeves WH, Bauer S, et al: Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 202:1575-1585, 2005.
66. Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, Dun H, Lu Y, Qu W, Schmidt AM, et al: Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 39:422-432, 2004.